These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). Merlos M, Giral M, Balsa D, Ferrando R, Queralt M, Puigdemont A, García-Rafanell J, Forn J. J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188 [Abstract] [Full Text] [Related]
31. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries. Qureshi AA, Karpen CW, Qureshi N, Papasian CJ, Morrison DC, Folts JD. Lipids Health Dis; 2011 Apr 14; 10():58. PubMed ID: 21489303 [Abstract] [Full Text] [Related]
35. Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo. Bullough DA, Zhang C, Montag A, Mullane KM, Young MA. J Clin Invest; 1994 Oct 14; 94(4):1524-32. PubMed ID: 7929829 [Abstract] [Full Text] [Related]
37. Further analysis of the inhibitory effects of dihydroergotamine, cyproheptadine and ketanserin on the responses of the rat aorta to 5-hydroxytryptamine. Doggrell SA. J Auton Pharmacol; 1992 Aug 14; 12(4):223-36. PubMed ID: 1512277 [Abstract] [Full Text] [Related]